Logo image of CRB.CA

CARIBOO ROSE RESOURCES LTD (CRB.CA) Stock Fundamental Analysis

TSX-V:CRB - TSX Venture Exchange - CA1420241087 - Common Stock - Currency: CAD

0.04  +0.01 (+33.33%)

Fundamental Rating

3

Taking everything into account, CRB scores 3 out of 10 in our fundamental rating. CRB was compared to 797 industry peers in the Metals & Mining industry. CRB has a great financial health rating, but its profitability evaluates not so good. CRB is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CRB has reported negative net income.
In the past year CRB has reported a negative cash flow from operations.
In the past 5 years CRB reported 4 times negative net income.
CRB had a negative operating cash flow in each of the past 5 years.
CRB.CA Yearly Net Income VS EBIT VS OCF VS FCFCRB.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500K -500K 1M -1M

1.2 Ratios

CRB has a Return On Assets of -15.32%. This is comparable to the rest of the industry: CRB outperforms 53.83% of its industry peers.
CRB has a Return On Equity (-16.23%) which is in line with its industry peers.
Industry RankSector Rank
ROA -15.32%
ROE -16.23%
ROIC N/A
ROA(3y)-14.98%
ROA(5y)0.2%
ROE(3y)-16.5%
ROE(5y)0.3%
ROIC(3y)N/A
ROIC(5y)N/A
CRB.CA Yearly ROA, ROE, ROICCRB.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CRB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CRB.CA Yearly Profit, Operating, Gross MarginsCRB.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

8

2. Health

2.1 Basic Checks

Compared to 1 year ago, CRB has about the same amount of shares outstanding.
The number of shares outstanding for CRB has been increased compared to 5 years ago.
The debt/assets ratio for CRB has been reduced compared to a year ago.
CRB.CA Yearly Shares OutstandingCRB.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
CRB.CA Yearly Total Debt VS Total AssetsCRB.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

2.2 Solvency

An Altman-Z score of 13.40 indicates that CRB is not in any danger for bankruptcy at the moment.
CRB's Altman-Z score of 13.40 is fine compared to the rest of the industry. CRB outperforms 75.93% of its industry peers.
CRB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 13.4
ROIC/WACCN/A
WACCN/A
CRB.CA Yearly LT Debt VS Equity VS FCFCRB.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M 2M

2.3 Liquidity

CRB has a Current Ratio of 4.20. This indicates that CRB is financially healthy and has no problem in meeting its short term obligations.
CRB has a better Current ratio (4.20) than 71.23% of its industry peers.
CRB has a Quick Ratio of 4.20. This indicates that CRB is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 4.20, CRB is in the better half of the industry, outperforming 71.48% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.2
Quick Ratio 4.2
CRB.CA Yearly Current Assets VS Current LiabilitesCRB.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M

More info and screens

0

3. Growth

3.1 Past

CRB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 37.50%, which is quite impressive.
EPS 1Y (TTM)37.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30.77%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CRB. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CRB.CA Price Earnings VS Forward Price EarningsCRB.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CRB.CA Per share dataCRB.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 0.02

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CRB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CARIBOO ROSE RESOURCES LTD

TSX-V:CRB (6/27/2025, 7:00:00 PM)

0.04

+0.01 (+33.33%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners7.17%
Ins Owner ChangeN/A
Market Cap2.32M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.45
P/tB 1.45
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.32%
ROE -16.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-14.98%
ROA(5y)0.2%
ROE(3y)-16.5%
ROE(5y)0.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 229.14%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.2
Quick Ratio 4.2
Altman-Z 13.4
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)965.62%
Cap/Depr(5y)943.48%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30.77%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y7.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y21.41%
OCF growth 3YN/A
OCF growth 5YN/A